Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
kerri-lee.wallom@pharm.ox.ac.uk

Telephone
+44 (0)1865 281116

Research groups

Platt Laboratory | Lysosomal and Sphingolipid Disorders

Kerri-Lee Wallom

Postdoctoral Research Assistant

Recent publications

Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.

Kilavuz S. et al, (2025), Orphanet J Rare Dis, 20

Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff Disease.

Platt N. et al, (2025), Cells, 14

Cholera intoxication of human enteroids reveals interplay between decoy and functional glycoconjugate ligands.

Singla A. et al, (2023), Glycobiology, 33, 801 - 816

Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels.

Te Vruchte D. et al, (2022), Mov Disord, 37, 2129 - 2134

Glycosphingolipid metabolism and its role in ageing and Parkinson's disease.

Wallom K-L. et al, (2022), Glycoconj J, 39, 39 - 53

More publications